$RMD

Resmed Inc.

  • NEW YORK STOCK EXCHANGE, INC.
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

PRICE

$271.8 -

Extented Hours

VOLUME

350,322

DAY RANGE

267.802 - 272.75

52 WEEK

164.77 - 272.75

Join Discuss about RMD with like-minded investors

profile
@dros #droscrew
recently

RMD the cow favorite

134 Replies 11 👍 11 🔥

profile
@Benlax #droscrew
recently

could carry peers like $RMD

55 Replies 6 👍 12 🔥

profile
@Benlax #droscrew
recently

rmd is money, dont own it but its always on the all time high list

44 Replies 11 👍 13 🔥

profile
@RedSunCap #droscrew
recently

RMD 200/210 call spread // 1k+ vs 3 (buy side)

84 Replies 15 👍 12 🔥

Key Metrics

Market Cap

39.55 B

Beta

0.80

Avg. Volume

460.93 K

Shares Outstanding

145.52 M

Yield

0.57%

Public Float

0

Next Earnings Date

2021-08-05

Next Dividend Date

Company Information

ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.

CEO: Michael Farrell

Website:

HQ: 9001 Spectrum Center Blvd San Diego, 92123-1438 California

Related News

  • OpenPR

    Therapeutic Respiratory Devices Market Share 2020 | Growth Projection, Future Key Insights, Sales Estimations, Size Analysis, Upcoming Trends and Business Overview By 2028 | ResMed, Fisher & Paykel Healthcare Limited, and BD

    30 Jul 2021, 10:16
  • Benzinga

    The Daily Biotech Pulse: Merck''s Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs

    29 Jul 2021, 12:15
  • Seeking Alpha

    Jefferies upgrades ResMed to hold on competitor sleep device recall

    28 Jul 2021, 16:53
  • GuruFocus

    Thoroughbred Financial Services, Llc Buys iShares Core MSCI Total International Stock ETF, ...

    27 Jul 2021, 22:38
  • AB Newswire

    IoT Medical Devices Market Study with Top Key Players ResMed. (U.S.), Koninklijke Philips N.V (Netherlands), Masimo(U.S.), BD. (U.S.), etc.

    27 Jul 2021, 21:56